Generation of CD8+ CTL specific to OVA257‐264 by vaccination with hsc70 fusion protein. C57BL/6 mice were immunized intraperitoneally with 10 µg OVA265‐280‐hsc70‐OVA257‐264, twice in a 1‐week interval. Two weeks after the second immunization, the spleen cells were stimulated in vitro with 10−6 M OVA257‐264 for 5 days. (a, upper panel) The resulting cells were stained with tetramer consisting of H‐2Kb and OVA257‐264 (MBL, Nagoya, Japan). (a, lower panel) CD8+ cells were sorted out by fluorescence‐activated cell sorting (FACS) Vantage. Cells in (a) were used for 51Cr‐release assay (b) and cytokine ELISPOT assay (c), as indicated.